CDK2-IN-15

• UNSPSC Description:

  CDK2-IN-15 (Compound 19) is an inhibitor of CDK2 with an IC50 of 2.9 μM. CDK2-IN-15 can be used for cancer research[1].

• Target Antigen:

  CDK

• Type:

  Natural Products

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/cdk2-in-15.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C1NC2=C3C1=CC4=C(OCO4)C3=C5C=CC(O)=C(OC)C5=C2

• Molecular Weight:

  309.27

• References & Citations:

  [1]Hegde VR, et.al. Semi-synthetic aristolactams--inhibitors of CDK2 enzyme. Bioorg Med Chem Lett. 2010 Feb 15;20(4):1384-7.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  1219915-83-9